Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 3, 2007, Pages 1298-1304

  Sandberg, Michael A ^a   Rosner, Bernard ^a   Weigel DiFranco, Carol ^a   Dryja, Thaddeus P ^a   Berson, Eliot L ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHODOPSIN; EYE PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RPGR PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLINDNESS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ELECTRORETINOGRAM; GENE MUTATION; HUMAN; LIGHT; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REGRESSION ANALYSIS; REGULATOR GENE; RETINITIS PIGMENTOSA; RETINITIS PIGMENTOSA GTPASE REGULATOR GENE; SURVIVAL; VISION TEST; VISUAL ACUITY; VISUAL FIELD; X CHROMOSOME LINKED DISORDER; ELECTRORETINOGRAPHY; FOLLOW UP; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RETINA; VISUAL DISORDER;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ELECTRORETINOGRAPHY; EYE PROTEINS; FOLLOW-UP STUDIES; GENETIC DISEASES, X-LINKED; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MALE; MIDDLE AGED; RETINA; RETINITIS PIGMENTOSA; RHODOPSIN; SURVIVAL ANALYSIS; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 34047251141     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0971     Document Type: Article

References (19)

1. Berson EL, Sandberg MA, Rosner B, et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol. 1985;99:240-251.
2. Berson EL, Rosner B, Weigel-DiFranco C, Dryja TP, Sandberg MA. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci. 2002;43:3027-3036.
3. Hong D, Pawlyk BS, Shang J, et al. A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model of X-linked retinitis pigmentosa (RP3). Proc Natl Acad Sci USA. 2000;97:3649-3654.
4. Sharon D, Bruns GAP, McGee TL, Sandberg MA, Berson EL, Dryja T. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Invest Ophthalmol Vis Sci. 2000;41:2712-2721.
5. Sharon D, Sandberg MA, Rabe VW, Stillberger M, Dryja TP, Berson EL. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet. 2003;73:1131-1146.
6. Kirkham TH, Meyer E. Visual field area on the Goldmann hemispheric perimeter surface: correction of cartographic errors inherent in perimetry. Curr Eye Res. 1981;1:93-99.
7. Drasdo N, Fowler CW. Non-linear projection of the retinal image in a wide-angle schematic eye. Br J Ophthalmol. 1974;58:709-714.
8. Holopigian K, Greenstein V, Seiple W, Carr RE. Rates of change differ among measures of visual function in patients with retinitis pigmentosa. Ophthalmology. 1996;103:398-405.
9. Grover S, Fishman GA, Anderson RJ, Alexander KR, Derlacki DJ. Rate of visual field loss in retinitis pigmentosa. Ophthalmology. 1997;104:460-465.
10. Iannaccone A, Kritchevsky SB, Ciccarelli ML, et al. Kinetics of visual field loss in Usher Syndrome type II. Invest Ophthalmol Vis Sci. 2004;45:784-792.
11. Sandberg MA, Brockhurst RJ, Gaudio AR, Berson EL. The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2005;46:3349-3354.
12. Clarke G, Collins RA, Leavitt BR, et al. A one-hit model of cell death in inherited neuronal degenerations. Nature. 2000;406:195-199.
13. Massof RW, Dagnelie G, Benzschawel T, Palmer RW, Finkelstein D. First order dynamics of visual field loss in retinitis pigmentosa. Clin Vis Sci. 1990;5:1-26.
14. Birch DG, Anderson JL, Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 1999;106:258-268.
15. Meindl A, Dry K, Herrmann K, et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet. 1996;13:35-42.
16. Vervoort T, Lennon A, Bird AC, et al. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet. 2000;25:462-466.
17. Ergun E, Hermann B, Wirtitsch M, et al. Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2005;46:310-316.
18. Brockhurst RJ, Sandberg MA. Optical coherence findings in occult macular dystrophy. Am J Ophthalmol. 2007;143:516-518.
19. Madreperla SA, Palmer RW, Massof RW, Finkelstein D. Visual acuity loss in retinitis pigmentosa: relationship to visual field loss. Arch Ophthalmol. 1990;108:358-361.